- Home
- CCCC vs XPOF Comparison
CCCC vs XPOF Comparison
Compare CCCC & XPOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCCC
- XPOF
- Stock Information
- Founded
- CCCC 2015
- XPOF 2017
- Country
- CCCC United States
- XPOF United States
- Employees
- CCCC N/A
- XPOF N/A
- Industry
- CCCC Biotechnology: Pharmaceutical Preparations
- XPOF Services-Misc. Amusement & Recreation
- Sector
- CCCC Health Care
- XPOF Consumer Discretionary
- Exchange
- CCCC Nasdaq
- XPOF Nasdaq
- Market Cap
- CCCC 104.4M
- XPOF 295.1M
- IPO Year
- CCCC 2020
- XPOF 2021
- Fundamental
- Price
- CCCC $2.26
- XPOF $10.04
- Analyst Decision
- CCCC Buy
- XPOF Buy
- Analyst Count
- CCCC 3
- XPOF 9
- Target Price
- CCCC $12.00
- XPOF $13.94
- AVG Volume (30 Days)
- CCCC 1.6M
- XPOF 788.3K
- Earning Date
- CCCC 07-31-2025
- XPOF 07-31-2025
- Dividend Yield
- CCCC N/A
- XPOF N/A
- EPS Growth
- CCCC N/A
- XPOF N/A
- EPS
- CCCC N/A
- XPOF N/A
- Revenue
- CCCC $39,783,000.00
- XPOF $317,536,000.00
- Revenue This Year
- CCCC N/A
- XPOF $1.62
- Revenue Next Year
- CCCC N/A
- XPOF $6.11
- P/E Ratio
- CCCC N/A
- XPOF N/A
- Revenue Growth
- CCCC 98.56
- XPOF N/A
- 52 Week Low
- CCCC $1.09
- XPOF $6.64
- 52 Week High
- CCCC $7.66
- XPOF $18.95
- Technical
- Relative Strength Index (RSI)
- CCCC 63.62
- XPOF 63.94
- Support Level
- CCCC $1.36
- XPOF $8.86
- Resistance Level
- CCCC $2.17
- XPOF $10.14
- Average True Range (ATR)
- CCCC 0.15
- XPOF 0.53
- MACD
- CCCC 0.05
- XPOF 0.28
- Stochastic Oscillator
- CCCC 67.11
- XPOF 93.97
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.
About XPOF Xponential Fitness Inc.
Xponential Fitness Inc is a curator of boutique fitness brands. Its diversified portfolio of brands includes Club Pilates, a Pilates brand in the United States; CycleBar, an indoor cycling brand in the United States; StretchLab, a concept offering one-on-one and group stretching services; Row House, a high-energy, low-impact indoor rowing workout; AKT, a dance-based cardio workout combining toning, interval and circuit training; YogaSix a franchised yoga brand; Pure Barre, a total body workout that uses the ballet barre to perform small isometric movements; Stride, a treadmill-based cardio and strength training concept; Rumble, a boxing-inspired full-body workout; and BFT, a functional training and strength-based program. Its key revenue source is franchise income.